We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
SM Energy
SM
$6.87B
| $21.4M | 0.04% |
677,338
-191,494
| -22% | -$5.41M |
|
452
PUT
Johnson & Johnson
JNJ
$625B
| $21.4M | 0.04% |
129,000
+25,900
| +25% | +$4.18M |
|
|
RBCP
453
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $21.2M | 0.04% |
200,000
-50,000
| -20% | -$5.32M |
|
454
Lantheus
LNTH
$6.59B
| $21.1M | 0.04% |
251,914
-837,148
| -77% | -$75.1M |
|
455
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
| $21.1M | 0.04% |
205,151
-163,300
| -44% | -$16.9M |
|
|
MRTX
456
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21.1M | 0.04% |
584,323
+31,709
| +6% | +$1.31M |
|
457
Stryker
SYK
$130B
| $21.1M | 0.04% |
69,151
+8,965
| +15% | +$2.59M |
|
458
PUT
State Street Technology Select Sector SPDR ETF
XLK
$124B
| $20.8M | 0.04% |
239,000
+238,200
| +29,775% | +$18.8M |
|
459
Tronox
TROX
$1.04B
| $20.7M | 0.04% |
1,627,463
+555,449
| +52% | +$6.98M |
|
460
CALL
Salesforce
CRM
$158B
| $20.6M | 0.04% |
97,700
-37,700
| -28% | -$7.7M |
|
461
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $20.6M | 0.04% |
277,300
+267,300
| +2,673% | +$20.1M |
|
462
Chemours
CC
$2.37B
| $20.5M | 0.04% |
+556,726
| New | +$17M |
|
463
Paychex
PAYX
$42.7B
| $20.5M | 0.04% |
183,537
-540,791
| -75% | -$59.1M |
|
464
GXO Logistics
GXO
$5.55B
| $20.5M | 0.04% |
326,130
-270,485
| -45% | -$15.2M |
|
465
Kraft Heinz
KHC
$30B
| $20.4M | 0.04% |
+574,125
| New | +$22.1M |
|
466
Merck
MRK
$318B
| $20.3M | 0.04% |
+176,087
| New | +$20M |
|
467
PUT
iShares China Large-Cap ETF
FXI
$4.31B
| $20.2M | 0.04% |
743,400
-267,900
| -26% | -$7.52M |
|
468
Lufax Holding
LU
$1.3B
| $20.1M | 0.04% |
3,513,684
+1,426,263
| +68% | +$9.43M |
|
469
Unilever
UL
$136B
| $20.1M | 0.04% |
+342,401
| New | +$20.3M |
|
470
MSCI
MSCI
$40.9B
| $19.9M | 0.04% |
42,299
-34,390
| -45% | -$16.8M |
|
471
Shutterstock
SSTK
$219M
| $19.8M | 0.04% |
406,934
+204,617
| +101% | +$11.7M |
|
472
Clearfield
CLFD
$374M
| $19.8M | 0.04% |
417,391
+28,307
| +7% | +$1.21M |
|
473
Nordic American Tanker
NAT
$1.37B
| $19.7M | 0.04% |
5,363,400
+952,534
| +22% | +$3.44M |
|
474
Sibanye-Stillwater
SBSW
$7.53B
| $19.7M | 0.04% |
3,151,595
+785,523
| +33% | +$6.2M |
|
475
HEICO Corp
HEI
$51.4B
| $19.5M | 0.04% |
110,429
-56,483
| -34% | -$9.52M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.